Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP795015.RA2RdEuQyMD6_bL4uLEqno_r1fiB35I_gfjmQeD7B-ReU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP795015.RA2RdEuQyMD6_bL4uLEqno_r1fiB35I_gfjmQeD7B-ReU130_assertion type Assertion NP795015.RA2RdEuQyMD6_bL4uLEqno_r1fiB35I_gfjmQeD7B-ReU130_head.
- NP795015.RA2RdEuQyMD6_bL4uLEqno_r1fiB35I_gfjmQeD7B-ReU130_assertion description "[Our results show that gene expression profile differences in the PI3K-AKT signaling pathway identify two subgroups of high-grade endometrial carcinomas with different molecular alterations (PI3K-AKT pathway vs p53 alterations) that may have distinct roles in endometrial carcinogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795015.RA2RdEuQyMD6_bL4uLEqno_r1fiB35I_gfjmQeD7B-ReU130_provenance.
- NP795015.RA2RdEuQyMD6_bL4uLEqno_r1fiB35I_gfjmQeD7B-ReU130_assertion evidence source_evidence_literature NP795015.RA2RdEuQyMD6_bL4uLEqno_r1fiB35I_gfjmQeD7B-ReU130_provenance.
- NP795015.RA2RdEuQyMD6_bL4uLEqno_r1fiB35I_gfjmQeD7B-ReU130_assertion SIO_000772 20173732 NP795015.RA2RdEuQyMD6_bL4uLEqno_r1fiB35I_gfjmQeD7B-ReU130_provenance.
- NP795015.RA2RdEuQyMD6_bL4uLEqno_r1fiB35I_gfjmQeD7B-ReU130_assertion wasDerivedFrom befree-2016 NP795015.RA2RdEuQyMD6_bL4uLEqno_r1fiB35I_gfjmQeD7B-ReU130_provenance.
- NP795015.RA2RdEuQyMD6_bL4uLEqno_r1fiB35I_gfjmQeD7B-ReU130_assertion wasGeneratedBy ECO_0000203 NP795015.RA2RdEuQyMD6_bL4uLEqno_r1fiB35I_gfjmQeD7B-ReU130_provenance.